Recro Pharma, Inc.(NASDAQ : REPH)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.20%||69.53||1.0%||$508.76m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.09%||204.64||1.9%||$479.45m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.12%||626.90||2.7%||$468.73m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-2.80%||4.16||0.7%||$290.80m|
|EXAS||EXACT Sciences Corp.||-4.54%||76.91||18.0%||$148.96m|
Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The firm offers integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products. The company was founded by Geraldine A. Henwood and Thomas F. Henwood on November 15, 2007 and is headquartered in Exton, PA.